Cyteir Therapeutics, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
0.34 | 48.77 | -99.3% | -5.55 | -106.12% |
| P/S |
|
0 | 33.76 | -100% |
|
|
| P/BV |
|
0.3569 | 4.82 | -92.6% |
|
|
| P/FCF |
|
-3.81 | 61 | -106.25% |
|
|
| Ev/Ebitda |
|
1.95 | -22.15 | -108.81% |
|
|
| Ev/S |
|
0 | 22.56 | -100% |
|
|
| Ev/FCF |
|
3.64 | 68.78 | -94.7% |
|
|
| E/P |
|
-0.3379 | 0.0178 | -2001.13% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | 4.98 | -100% | -49656.25 | -100% |
| ROE |
|
-26.35 | 9.61 | -374.17% |
|
|
| ROA |
|
-25.21 | 0.3443 | -7424.37% |
|
|
| ROIC |
|
-80.34 | 7.63 | -1152.35% |
|
|
| ROS |
|
0 | -25.17 | -100% |
|
|
| ROCE |
|
-33.02 | 15.35 | -315.09% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0184 | -3.68 | -99.5% | -0.0185 | -0.366% |
| Nеt Debt/Ebitda |
|
3.03 | -3.44 | -188.26% |
|
|
| Debt/Ratio |
|
0.0058 | 0.1985 | -97.08% |
|
|
| Debt/Equity |
|
0.5229 | 1.66 | -68.54% |
|
|
| Debt/Net Income |
|
-0.0268 | 10.32 | -100.26% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5442 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5442 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | -56.89 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
210.26 | -54.68 | -484.53% | ||
| Growth impulse Net Income in 5 years |
|
121.43 | -58.33 | -308.18% | ||
| Growth impulse FCF in 5 years |
|
43.27 | -49.48 | -187.45% | ||
| Growth impulse EPS in 5 years |
|
-807.79 | -32.41 | 2392.41% |
IP Score
4.26/10
